Study of Immune Hot and Cold Tumors in Head and Neck Cancer
Author Information
Author(s): Benjamin H. Jenkins, Ian Tracy, Maria Fernanda S. D. Rodrigues, Melanie J. L. Smith, Begoña R. Martinez, Mark Edmond, Sangeetha Mahadevan, Anjali Rao, Hailing Zong, Kai Liu, Abhishek Aggarwal, Li Li, Lauri Diehl, Emma V. King, Jamie G. Bates, Gareth J. Thomas
Primary Institution: University of Southampton, Southampton, UK
Hypothesis
Fibroblast phenotypes vary between immune-hot (HPV+ve) and immune-cold (HPV-ve) HNSCC subtypes, reflecting their multifaceted role in anti-tumor immunity.
Conclusion
The study identifies distinct fibroblast subtypes associated with different immune environments in head and neck cancer, with implications for immunotherapy response.
Supporting Evidence
- FRC-like fibroblasts were significantly enriched in immune-hot HPV+ve tumors.
- Higher levels of FRC-like fibroblasts were associated with better survival in patients receiving immunotherapy.
- Distinct fibroblast subtypes were identified through single-cell RNA sequencing.
- The study highlights the role of fibroblasts in shaping the immune landscape of tumors.
Takeaway
This study looks at how different types of fibroblasts in tumors can help or hurt the immune system's ability to fight cancer.
Methodology
Single-cell and spatial transcriptomic analysis of head and neck squamous cell carcinoma samples.
Potential Biases
Potential biases in patient selection and sample processing could affect the results.
Limitations
The study primarily focuses on head and neck cancer and may not be generalizable to other cancer types.
Participant Demographics
The study included 24 patients with head and neck squamous cell carcinoma, comprising 13 HPV+ve and 11 HPV-ve cases.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website